Device companies already enjoy big profit margins and are finding ways to avoid the impact of President Trump's tariffs.

The surgical robot maker is considering operational changes to counter tariff impacts on sales and demand but foresees no substantial benefits this year, Jamie Samath, chief finan ...

CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.

CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend ...

RBC Capital lowered the firm’s price target on Intuitive Surgical (ISRG) to $630 from $670 and keeps an Outperform rating on the shares as part ...

At the time of this writing, global economic concerns and Intuitive Surgical's mixed outlook have caused shares of the medical device giant to drop by about 18% from the all-time high they set in ...

Intuitive (Nasdaq: ISRG) announced two studies supporting the use of robotic-assisted surgery and its benefits to patients.

While Intuitive is still reporting steady growth in the placement of its da Vinci surgical robots—as well as the number of procedures they have performed—the company said it expects to take a ...

October 17, 2024 Intuitive beats quarterly profit estimates on strong demand for surgical robots Medical device maker Intuitive Surgical beat Wall Street estimates for third-quarter profit on ...

Intuitive Surgical is warning that President Donald Trump's import taxes and retaliation from trade partners could have a ...

Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and ...